Skip to content

LIMINAL BIOSCIENCES INC.

CIK 0001351172

← back to feed
Revenue (TTM)
401K
−37.6% YoY Q2 Jun 2023
Net Income (TTM)
622K
−94.9% YoY Q2 Jun 2023
EPS Diluted (TTM)
—
Q2 Jun 2023
Gross Margin
—
Q2 Jun 2023
Operating Margin
—
Q2 Jun 2023
Net Margin
155.1%
Q2 Jun 2023
Free Cash Flow (TTM)
—
Q2 Jun 2023
Cash
19.31M
Q2 Jun 2023
Total Debt
—
Q2 Jun 2023
Shares Outstanding
31.04M sh
Q2 Jun 2023

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings